rs777514296
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 2P and 3B. PM2BP4_ModerateBS1_Supporting
The NM_000628.5(IL10RB):c.718G>A(p.Gly240Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000125 in 1,613,866 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000628.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IL10RB | ENST00000290200.7 | c.718G>A | p.Gly240Ser | missense_variant | Exon 6 of 7 | 1 | NM_000628.5 | ENSP00000290200.2 | ||
IFNAR2-IL10RB | ENST00000433395.7 | c.1378G>A | p.Gly460Ser | missense_variant | Exon 12 of 13 | 5 | ENSP00000388223.3 |
Frequencies
GnomAD3 genomes AF: 0.000197 AC: 30AN: 152058Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000139 AC: 35AN: 251490Hom.: 0 AF XY: 0.000125 AC XY: 17AN XY: 135920
GnomAD4 exome AF: 0.000117 AC: 171AN: 1461808Hom.: 0 Cov.: 32 AF XY: 0.000131 AC XY: 95AN XY: 727222
GnomAD4 genome AF: 0.000197 AC: 30AN: 152058Hom.: 0 Cov.: 31 AF XY: 0.000242 AC XY: 18AN XY: 74270
ClinVar
Submissions by phenotype
Inflammatory bowel disease 25 Uncertain:2
This sequence change replaces glycine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 240 of the IL10RB protein (p.Gly240Ser). This variant is present in population databases (rs777514296, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with IL10RB-related conditions. ClinVar contains an entry for this variant (Variation ID: 566702). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
Inborn genetic diseases Uncertain:1
The c.718G>A (p.G240S) alteration is located in exon 6 (coding exon 6) of the IL10RB gene. This alteration results from a G to A substitution at nucleotide position 718, causing the glycine (G) at amino acid position 240 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Uncertain:1
BP4 -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at